Noninvasive Blood Glucose Monitoring Using Otoacoustic Emissions

Status unconfirmed

Conditions studied: Diabetes

In brief

The purpose of the research is to determine whether a noninvasive hearing test may be used to predict blood glucose in people with diabetes.

Key facts

Study ID

NCT01073137

Run by

Portland VA Medical Center

People needed

44

Starts

2006-06-01

Expected to finish

2010-06-01

Last updated by the study team

2010-02-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older
• Diabetes
• Normal hearing
• Hemoglobin A1C of 5.5-8%

You may not qualify if…

• Volunteers may not participate if they have peripheral neuropathy
• visual impairment due to diabetic retinopathy
• organ failure (kidney, liver heart, or lungs)
• severe or unstable cardiovascular disease
• active alcohol or drug abuse
• schizophrenia
• bipolar disorder
• active major depressive disorder
• active foot ulcerations
• active viral or other infections such as HIV
• hepatitis, or pneumonia
• serious renal
• cardiac or cognitive dysfunction.

Where it is running

• Portland VA Medical Center — Portland, Oregon, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.